Kato Noriko, Takahashi Genichiro, Kumegawa Koichi, Kabata Yoshiaki, Tsuneoka Hiroshi
Department of Ophthalmology, Jikei University, School of Medicine, Tokyo, Japan ; Katsushika Medical Center, Tokyo, Japan.
Department of Ophthalmology, Jikei University, School of Medicine, Tokyo, Japan.
Clin Ophthalmol. 2015 Aug 18;9:1491-8. doi: 10.2147/OPTH.S86504. eCollection 2015.
We investigated indications and early postoperative treatment for Ex-PRESS(®) insertion for glaucoma by comparing postoperative outcomes with those for standard trabeculectomy.
Ex-PRESS insertion was performed in 21 eyes and standard trabeculectomy (TLE) in 22 eyes. Mean intraocular pressure (IOP) in the 6 months after surgery, success rate for postoperative IOP decline, postoperative complications, postoperative treatment, filtering blebs, and indications were then retrospectively investigated.
Mean postoperative IOP did not differ significantly between the groups at any observation time for 6 months after surgery. Further, it did not differ between either the groups of patients with primary open-angle glaucoma (POAG) and neovascular glaucoma (NTG), or the patients with primary open-angle glaucoma and NTG in the Ex-PRESS group. Comparison of success rates in reduction of postoperative IOP between the groups under the following four survival conditions showed no significant differences: postoperative IOP <30% of the preoperative IOP, complete success (no additional ophthalmic solution), and qualified success (ophthalmic solution required); 5 mmHg ≤ postoperative IOP ≤21 mmHg, complete success (no additional ophthalmic solution), and qualified success (ophthalmic solution required). With regard to postoperative complications and postoperative treatment, the incidence of hyphema was significantly lower in the Ex-PRESS group, but no other significant intergroup differences were seen. The height of the filtering bleb was lower in the Ex-PRESS group.
Postoperative outcomes in the Ex-PRESS and TLE groups were comparable. The incidence of hyphema was significantly lower in the Ex-PRESS group. Ex-PRESS insertion appears to be useful in patients with NTG and in those prone to postoperative bleeding. There were no significant intergroup differences in postoperative treatment. Assessment of outcome after Ex-PRESS insertion was difficult in some patients. Postoperative treatment should be developed to suit the specific requirements of Ex-PRESS insertion.
通过比较Ex-PRESS(®)青光眼植入术与标准小梁切除术的术后结果,我们研究了Ex-PRESS青光眼植入术的适应症及术后早期治疗。
对21只眼行Ex-PRESS植入术,22只眼行标准小梁切除术(TLE)。回顾性研究术后6个月的平均眼压(IOP)、术后眼压下降成功率、术后并发症、术后治疗、滤过泡及适应症。
术后6个月的任何观察时间,两组间平均术后眼压均无显著差异。此外,原发性开角型青光眼(POAG)患者组与新生血管性青光眼(NTG)患者组之间,以及Ex-PRESS组中POAG和NTG患者之间,平均术后眼压也无差异。在以下四种生存条件下比较两组术后眼压降低成功率,无显著差异:术后眼压<术前眼压的30%、完全成功(无需额外眼药)和合格成功(需要眼药);5 mmHg≤术后眼压≤21 mmHg、完全成功(无需额外眼药)和合格成功(需要眼药)。关于术后并发症和术后治疗,Ex-PRESS组前房积血发生率显著较低,但未见其他显著组间差异。Ex-PRESS组滤过泡高度较低。
Ex-PRESS组和TLE组术后结果具有可比性。Ex-PRESS组前房积血发生率显著较低。Ex-PRESS植入术似乎对NTG患者和易于术后出血的患者有用。术后治疗方面两组无显著差异。部分患者难以评估Ex-PRESS植入术后的结果。应制定适合Ex-PRESS植入术特殊要求的术后治疗方案。